ARCHIVES

NCI-Approved Trials Listed

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

November 25, 2011

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

May 9, 2003

Holland, Hoogstraten Give Up Chairmanships Of CALGB, SWOG

March 6, 1981

Minority Demonstration Centers Concept

May 12, 1989

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

DCBD Board Rejects Breast Cancer Multiple Markers Concept Proposal

November 4, 1983